SignaCor Therapeutics
Startup · Northern Ireland, United Kingdom
Northern Ireland based developer of a first-in-class treatment for hypertrophic cardiomyopathy; won the cardiovascular Discovery Spark cohort and 250k GBP from Zinc.
Recent activity confirmed, checked October 18, 2026.
2 relationships with other organizations documented in IE research. Members see who they are and the evidence.
In context
SignaCor Therapeutics is one of 330 startups in the United Kingdom listed in the Innovative EcoSystems registry.
Startups are young companies building new products or business models.
The United Kingdom scores 67.4 out of 100 on the IEPA (2024 edition), ranking 24 of 117 economies.
See the United Kingdom on the IEPA ↗
More startups in the United Kingdom
- Optellum
Oxford - Magic Notion
Guildford - Sporegen
- Machine Discovery
Oxford - OhmSpace
Southampton - Nucleolus Software
Southampton - Aquark Technologies
Southampton - Mantisonix
Guildford